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Abstract: Hepatitis C (HCV) is one of the main causes of liver transplantation (OLT). Previously we have reported that high serum C RNA level
correlates with the severity of histopathological signs and poor clinical outcome. The core antigen of virus C is known to interfere with chaper-
ones in the hepatocytes, results in an endoplasmic reticulum (ER) stress. In this study HCV positive liver transplanted patients were evaluated,
whether there are correlations among chaperone expression, recurrence and viral titer. Patients were enrolled after surviving the first month fol-
lowing OLT. Sera were collected regularly, and biopsies were taken on demand following OLT. The diagnosis of recurrent HCV was proven by
Knodell-Ishak scoring. In this case ribavirin+interferon were initiated, and maintained for one year. All chaperones were upregulated in the trans-
planted liver graft showing recurrent hepatitis C disease. ATF6, GP96, GRP78, CNX and CLR chaperones were upregulated significantly com-
pared to their levels in normal livers. Except for one chaperone, the level of upregulation did not correlate with the serum’s HCV-RNA titre: the
only difference between Group1 and 2 (RNA titre above and below 8.78 106 respectively) was that the level of ATF6 was 1.6 times higher in
Group1 compared to Group2. The expression of all chaperones was reduced, and some even became downregulated after the interferon treatment.
In accordance with the literature our results suggest that hepatitis C might induce apoptosis through ER-stress. Those cells exposed to a high C
viral load, had a lower chance to be eliminated.
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Introduction
Hepatitis C is one of the main causes of liver transplan-
tation. Recurrence of the viral disease is unavoidable,
however, there are differences in the timing and clinical
course. The prognostic value of the postoperative HCV-
RNA titre in recurrent HCV infection following OLT is
controversial [1, 2, 3]. We have reported previously the
correlation of the high C-RNA serum level following
OLT, the severity of histopathological signs and the poor
clinical outcome [4]. This is consistent with other reports
[5]. The role of apoptosis in the recurrence of HCV fol-
lowing OLT is known [6]. Hepatitis C virus is a positive-
strand RNA virus which belongs to the Flaviviridae fam-
ily [7]. The core antigen of the C virus is known to
interfere with the chaperones in the hepatocytes, which
results in an endoplasmic reticulum stress (ERS). Molec-
ular chaperons are mostly residents of the endoplasmic
reticulum (ER) membrane. They are responsible for
proper folding of the de novo synthetised proteins. Un-
or misfolded proteins stay in the lumen of ER causing
ERS that results in the unfolded protein response (UPR).
On one hand the UPR cascade activates apoptosis via the
NF-lB system, but it also has an antiapoptotic effect. The
focus of our interest was to determine whether there are
differences in the expression of resident membrane chap-
erones between patients characterized by a high serum
viral titre and low replication after OLT. We also evalu-
ated whether the effect of interferon treatment can be de-
tected in the chaperon expression. In order to determine
this we have enrolled the same cohort of patients that we
had evaluated in our previous study [4].
Interventional Medicine & Applied Science, Vol. 1 (1), pp. 35–40 (2009)
DOI: 10.1556/IMAS.1.2009.1.5
IMAS_2009_1_impjav:IMAS_2009_1_impjav  12/1/09  11:13 AM  Page 35
ISSN 2061-1617 © 2009 Akadémiai Kiadó, Budapest 36 Interventional Medicine & Applied Science
Nemes et al.
Patients, material and methods
Patients, biopsies, definition of the study group
All patients were enrolled after surviving the first month
following OLT. Sera were collected 1, 2, 3, 6 and 12
months after OLT for HCV-RNA PCR (RT-PCR Roche
version 2.0; expressed in million copy/ml). Genotypes
were also detected [8]. Biopsies were taken after liver
transplantation within 6 months on demand and/or at
every year per protocol. The diagnosis of recurrent HCV
was histologically proven by Knodell-Ishak scoring [9,
10]. In case of proven HCV recurrence ribavirin+inter-
feron were initiated as soon as possible, and maintained
for one year. By the end of the 52nd week of IFN treat-
ment a control biopsy was taken, and was also evaluated
as mentioned above. If the recurrence was detected
within 1 year postOLT we defined it as early viral recur-
rence, while late recurrence was considered when it oc-
curred over the first 12 months. We determined groups
by the serum HCV-RNA titres. A cut off point was set by
a receiver operating curve (ROC) analysis that had been
performed (SPSS Programme 13.0) between early and
late recurrence using the highest measured HCV-RNA
titre within the first 6 months. This proved to be
8.78×106 copy/ml (area: 0.84; specificity: 77%; sensi-
tivity: 95%; p=0.009), meaning that patients with an
early recurrence had higher HCV-RNA titer (Group1)
while patients with a late recurrence had a lower HCV-
RNA titer (Group2). As we have reported earlier [4]
there were no statistical differences between the two
Groups with regards to donor age, gender and volume
of transfusion given to the donor, as well as the type of
organ perfusion fluid (University Wisconsin-UW or hys-
tidin-triptophan-ketoglutarate-HTK). Furthermore no
differences were found between the groups in recipient
age, gender, Child-Pugh score, transfusion during opera-
tion; postoperative bleeding and technical complications
(vascular, biliary) and in the need for renal replacement
therapy. In Group1 more patient had acute rejection
episode (53% vs. 22%; p=0.04) with a consecutive anti-
rejection bolus treatment (53% vs.17%; p=0.02). Infec-
tious complications (69% vs. 31%; p=0.007) were statis-
tically more common in Group1 than in Group2. Sepsis
was also more common (75% vs. 25%; p=0.12) without
a statistical relevance.
Thirty-six (36) formalin-fixed, paraffin-embedded
biopsy specimens from liver transplanted patients (28
cases with low HCV titre and 8 cases with high HCV
titre) were analyzed by molecular biological methods.
Five (5) pieces of normal liver tissue obtained from
healthy individuals who had died in an accidents were
used for control. The elapsed time between death and tis-
sue fixation was 6 to 12 hours. All samples were taken
with informed consents of the patients in accordance with
the Helsinki declaration and with the permission of the
local ethical committee.
Molecular biology methods
Real-Time polymerase chain reaction (RT-PCR) analysis
of XBP1 (x-box protein) total, XBP1 spliced, ATF6 (ac-
tivating transcription factor 6), HSP27 (heat-shock pro-
tein 27), GP96 (glycoprotein of 96 kDa), GRP78 (glu-
cose-regulated protein 78), CNX (calnexine), CLR
(calreticuline) and GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) mRNA expression.
RNA Isolation
Total ribonucleic acid (RNA) from formalin-fixed, paraf-
fin-embedded biopsy specimens was isolated with High
Pure RNA Paraffin Kit (Roche, Indianapolis, Indiana,
USA), after eight pieces of 5-µm-thick sections were cut
from each tissue block. Proteinase K (Applied Biosys-
tems) digestion time was 16 hours for each sample. All
purifications were performed in accordance with the
manufacturer’s protocol. After total RNA isolation, sam-
ples were kept at –80°C until further use. Total RNA in-
tegrity was verified.
Reverse Transcription of RNA
Total RNA (500 ng) was reverse transcribed for 50 min-
utes at 42°C in 30 µl with MulV reverse transcriptase
(Applied Biosystems, Foster City, CA, USA) in the pres-
ence of RNase inhibitor (Applied Biosystems) using Ran-
dom Hexamers (Applied Biosystems).
Real-Time Quantitative RT-PCR
Real-time PCR reaction was performed with 2 µl cDNA
templates in a total volume of 25 µl, using ABI Prism
7000 sequence detection system (Applied Biosystems).
Each PCR was conducted in 25 µl volume of SYBR
Green Supermix (Bio-Rad, Hercules, CA, USA,
1708851). Primary sequences (primers) were as shown
in Table I.
Each PCR reaction was done in duplicate in 96-well
plates, for 2 minutes at 95°C for initial denaturing, then
40 cycles at 95°C for 20 seconds, at 60°C for 30 seconds
and 72°C for 1 minute. Data analysis and statistical eval-
uation were performed by REST (relative expression soft-
ware tool, www.gene-quantification.info), using GAPDH
as a reference gene. Relative expression was calculated by
the aforementioned software, according to the following
(simplified) equation:
E (target gene) ∆CP (mean control – sample control)
R=_______________________________________
E (reference gene) ∆CP (mean control – sample control)
R=relative expression; E=effectiveness of PCR reac-
tion (the multiplication factor of PCR increase/cycle,
which ideally would be 2, representing the complete du-
plication of genetic material in each cycle); DCP=cross-
ing point, the number of cycles, when the amount of
RNA exceeds the threshold value
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Results
Chaperone expressions are shown in Table II. All chap-
erones were up regulated in the transplanted liver graft
tissues showing recurrent hepatitis C disease. ATF6,
GP96, GRP78, CNX and CLR chaperones were upreg-
ulated significantly compared to their levels in normal liv-
ers. Except for one chaperone, the level of upregulation
did not correlate with the serum’s HCV-RNA titre: the
only difference between Group1 and 2 (RNA titre above
and below 8.78 106 respectively) was that the level of
ATF6 was 1.6 times higher in Group1 compared to
Group2. (5.8 vs. 3.7; p=0.05) This difference disap-
peared after interferon treatment. A homogeneous dif-
ference was found comparing biopsies taken before and
after a year of interferon treatment: the relative expression
of all chaperones was reduced. Moreover total and spliced
XBP, as well as HSP27 became downregulated during in-
terferon treatment. (See Table II and Figure 1). On the
other hand no difference was found between patients
with previously high and low RNA replication.
Discussion
Hepatitis C virus (HCV) is a positive-strand RNA virus
which belongs to the Flaviviridae family. Its genome con-
tains a long open reading frame of 9,030 to 9,099 nu-
cleotides that is translated into a single polyprotein of
3,010 to 3,033 amino acids. The viral genome is framed
by a non-readable region on both 5’ and 3’ ends [11].
There is an untranslated region (5-UTR) on the 5’ ter-
minal of the genome which is a characteristic of hepatitis
C virus. The HCV 5’-NCR also functions as an internal
ribosome entry site (IRES) permitting cap-independent
translation [12]. Cleavages of this polyprotein are co- and
posttranslational and generate at least ten polypeptides
including 2 glycoproteins, E1 and E2. HCV glycopro-
teins E1 and E2 interact to form complexes. Characteri-
Table I Chaperone primer sequences used for PCR reactions
Chaperone Primer No. of basis pairs
XBP1total F 5’CATGGCCTTGTAGTTGAGAACCA-3’ (378-400) 95
XBP1total R 5’ACTTCATTCCCCTTGGCTTCC-3’ (452-472)
GI: 18148379
XBP1spliced F 5’TGAGTCCGCAGCAGGTGC-3’ (494-511) 81
XBP1spliced R 5’TCTGAAGAGTCAATACCGCCAGA -3’ (552-574)
GI: 18148381
ATF6 F 5’TGCTTCACCCAGAAGTTATCAAGAC -3’ (1705-1729) 92
ATF6 R 5’GCAGGTGATCCCTTCGAAATG -3’ (1796-1776)
GI: 56786156
HSP27 F 5’CGTGTCCCTGGATGTCAACC -3’ (395-414) 87
HSP27 R 5’TCGTGCTTGCCGGTGATC -3’ (464-481)
GI: 4996892
GRP78 F 5’ACCATCCCGTGGCATAAACC -3’ (1353-1372) 108
GRP78 R 5’ACATCAAGCAGTACCAGGTCACCT -3’ (1437-1460)
GI: 18044380
GP96 F 5’TAAGCTCTATGTGCGCCGTGT -3’ (1332-1352) 122
GP96 R 5’TCTCGCGGGAAACATTCAAG -31 (1434-1453)
GI: 4507676
Calnexin F 5’CTCCCAAGGTTACTTACAAAGCTCC-3’ (275-299) 89
Calnexin R 5’AATCCACCCTGACAGAGTTCCTC-3’ (341-363)
GI: 31542290
Calreticulin F 5’TGTTTGGTCCCGACATCTGTG-3’ (460-480) 102
Calreticulin R 5’CCTTGCAACGGATGTCCTTG-3’ (542-561)
GI: 5921996
GAPDH F 5’CATTGACCTCAACTACATGG-3’ (186-205) 121
GAPDH R 5’GAAGATGGTGATGGGATTTC-3’ (287-306)
GI: 7669491
F: forward, R: reverse
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zation of HCV glycoprotein complex formation indicated
that a majority of these proteins are misfolded aggregates
and their tendency toward aggregation could be an in-
trinsic property of HCV glycoproteins [7]. The UTR re-
gion is the most stable region of the genome, therefore
this is the common target for genotype and serum RNA
evaluations. The native virus polyprotein is dissected by
its own proteinases. This is how the structural and non-
structural (enzyme) proteins born. The virus’ proteinss
are the following: core (capsid) protein, E1 (envelop),
E2, NS2, NS3, NS4a, NS4b, NS5a, and NS5b. The core
protein suppresses the apoptotic process in vitro [13].
There is an association between the mutations of NS5a
region and interferon resistance. It was also reported that
the NS5a region suppresses the p53 mediated apoptosis
during HCV infection, which might be in association
Table II Relative expression of chaperones (compared to normal liver) in the two groups, before and after interferon treatment following liver
transplantation (+means upregulation and – means downregulation)
HCV-RNA titer above 8.78×106 copy/ml compared
to normal healthy liver sample
HCV-RNA titer under 8.78×106 copy/ml compared
to normal healthy liver sample
Before IFN After IFN Before IFN After IFN
Relative expression (p value) Relative expression (p value)
XBP1 total +1.60 (ns) –1.07 (ns) +1.86 (ns) +1.86 (ns)
XBP1 spliced +1.53 (ns) –1.07 (ns) +2.48 (ns) +1.26 (ns)
ATF6 +5.82 (0.001) +2.85 (0.03) +3.69 (0.001) +3.42 (0.03)
HSP27 +1.19 (ns) –1.05 (ns) +1.25 (ns) –1.11 (ns)
GP96 +5.35 (0.001) +3.04 (0.04) +5.06 (0.001) +3.46 (0.02)
GRP78 +2.28 (0.01) +1.35 (ns) +3.34 (0.002) +2.30 (ns)
Calnexin +2.89 (0.01) +1.71 (ns) +3.29 (0.001) +1.68 (ns)
Calreticulin +3.11 (0.009) +1.71 (ns) +2.43 (0.003) +1.99 (ns)
Fig. 1. Relative expression of chaperones XBP-total, XBP-spliced and ATF6. Left side: Group2 (serum HCV-RNA PCR titre below the cut off
– 8 million copy/ml). Right side: Group1 (serum HCV-RNA PCR titre above the cut off). Chaperones are indicated with separate
colours shown on the legend. Dark shade of the relevant colour indicates the relative expression before, while light one after interferon
treatment
Nemes et al.
IMAS_2009_1_impjav:IMAS_2009_1_impjav  12/1/09  11:13 AM  Page 38
Interventional Medicine & Applied Science 39 ISSN 2061-1617 © 2009 Akadémiai Kiadó, Budapest
Chaperones in HCV recurrence after l iver transplantation
with hepatocarcinogenesis [14]. The NS5b protein is en-
coded in the most stable part of the genome. Structural
proteins are located on the aminoterminal end, while en-
zyme proteins are on the carboxyterminal end of the
polyprotein. Non-structural proteins, including NS3,
NS4 and NS5A/B, make up a ribonucleoprotein replica-
tion complex associated with the endoplasmic reticulum
(ER) membrane [12]. During their synthesis the
ectodomains of HCV glycoproteins are targeted to the
lumen of the endoplasmic reticulum (ER), where they
are modified [15]. During polyprotein maturation, gly-
cans promote glycoprotein folding either directly, by in-
creasing the solubility of a protein, or indirectly, by in-
teracting with ER chaperones. Mutated E1 proteins
interfere with the folding of E2, leading to misfolding of
an E2 domain that aggregates with E1 [16]. Calnexin
(CNX) interacts with HCV glycoproteins and this chap-
erone has been shown to be involved in the assembly of
the noncovalent E1E2 heterodimer [7]. It appears that
the co precipitation of mutant E1 proteins with calnexin
depends on the number of glycans present on the pro-
teins and this may account for the low level of proper
folding of some mutant E1 proteins. Furthermore a mu-
tation at position N1 and predominantly at position N4
dramatically reduced the efficiency of the formation of
noncovalent E1E2 complexes [16]. HCV nonstructural
proteins are localized to the ER membrane, where they
form a ribonucleoprotein (RNP) complex, that engages
in the replication of the viral genome, an event necessary
for establishing the infectious process in hepatocytes. The
association of the replication complex with the ER mem-
brane induces ER stress. This stress elicits the activation
of intracellular signalling pathways from the ER to the
nucleus [12]. The ER is sensitive to a variety of cellular
stresses, including the alteration of Calcium homeostasis
and inhibition of protein glycosylation [17]. These
stresses inhibit protein folding in the ER, resulting in the
accumulation of misfolded proteins in the organelle. Cells
can respond to ER stress by activating two functionally
separate signalling pathways, the unfolded protein re-
sponse (UPR) and the ER overload response (EOR)
[18]. HCV proteins induce both of these signalling path-
ways. The HCV protein NS5A stimulates EOR after dis-
turbing intracellular calcium levels, leading to the activa-
tion of NF-lB and STAT-3 [19]. The HCV structural
protein E2 can accumulate in the ER as misfolded ag-
gregates inducing UPR [12]. ATF6 is a transmembrane
protein localized to the ER; the protein is regulated post-
translationally by ER stress. Upon ER stress, ATF6 is
cleaved at the cytoplasmic face of the ER membrane and
the resulting 50-kDa N-terminal domain, pATF6_(N) is
translocated to the nucleus, where it transcriptionally ac-
tivates ER chaperones whose promoters harbour several
ATF6 binding sites and lead to the induction of GRP78,
a major target of the UPR. Therefore the cap-indepen-
dent translation directed by the HCV-IRES and GRP78-
IRES is stimulated [12] Overexpression of GRP78 delays
the onset of apoptosis induced by unfolded proteins [20]
ATF6 also initiates the transcriptional induction of ER
chaperone and XBP1 genes in an ERSE-dependent man-
ner [21]. XBP1 mRNA is spliced by IRE1, an ER stress
transducer. XBP1 is a transcription factor that activates
the mammalian UPR through ERSE sequences, similarly
to ATF6. The HCV replication seems to alter the typical
course of the UPR signalling pathway to prolong its sur-
vival in hepatocytes [12]. Lee et al. [22] reported that
HCV E2 protein blocks apoptosis induced by HCV
infection and the host immune system, through over-
production of GRP94: the activation of the well-known
antiapoptotic NF-kappaB was mediated by HCV-E2-
induced expression of the molecular chaperone glucose-
regulated protein 94 (GRP94). Therefore HCV E2 plays
an important role in persistent HCV infection. Hepatitis
C virus (HCV) non-structural protein 5A (NS5A) is a
component of a viral replicase and is well known to mod-
ulate the functions of several host proteins. A report from
Okamoto et al. [23] suggests that NS5A specifically in-
teracts with FKBP8, a member of the FK506-binding
protein family, but it does not interact with other ho-
mologous immunophilins. Since FK-506 (tacrolimus,
Prograf) is a basic immunosuppressant agent used in liver
transplantation, it is a fact of interest that immunopre-
cipitation analyses revealed that FKBP8 forms a complex
with HSP90 and NS5A. They found that treatment of
HCV replicon cells with geldanamycin, an inhibitor of
Hsp90, suppressed RNA replication in a dose-dependent
manner. In their later studies Okamoto et al. [24] re-
ported that examination of individual fields of the replicon
cells by both fluorescence microscopy and electron mi-
croscopy revealed that FKBP8 is partially co-localized with
NS5A in the cytoplasmic structure known as the mem-
branous web. These results suggest that a specific interac-
tion of NS5A with FKBP8 in the cytoplasmic compart-
ment plays a crucial role in the replication of HCV.
In our study we found a significant upregulation of
chaperons in the hepatocytes infected with hepatitis C
virus. Patients whose serum contained a high (more than
8.78 million copy/ml) RNA titre after OLT showed an
increasedATF6 upregulation. After one year of interferon
treatment the upregulation was reduced in all chaper-
ones, and in some cases (XBP and HSP27) downregula-
tion occurred. The prolonged and severe ER-stress might
cause apoptosis via the activation of C/EB1 homologous
protein (CHOP) or JUNNH2-terminal kinase (JNK), or
caspase 12, or by calcium depletion occurring in the en-
doplasmic reticulum during ER stress [25, 26]. On the
other hand the deliberation of reactive oxygen species
(ROS) activate STAT3 and NFlB enzymes, which pro-
tect hepatocytes from apoptosis by promoting the ex-
pression of certain genes [12]. In accordance with the lit-
erature [27] our results suggest that hepatitis C might
induce apoptosis through ER-stress, however it could
also limit the intensity of hepatocyte apoptosis. The the-
ory – liver cells exposed to a high C viral load, had a lower
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chance to be eliminated by this pathway – might explain
why liver transplanted patients with extreme RNA-PCR
titres had a worse prognosis. However it must also be
taken into account that other causes of post liver trans-
plant ER-stress also exists: Emadali et al. [28] reported
that the expression of certain molecular chaperones in-
duced by ER stress, are differentially affected upon is-
chemic-reperfusion injury, thus suggesting that distinct
ER stress responses are activated during each phase of
liver transplantation. The research of the field on ex-
tended and prospective biopsy-material is planned.
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